• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障通透性增加与痴呆症和糖尿病有关,但与淀粉样蛋白病理或载脂蛋白E基因型无关。

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.

作者信息

Janelidze Shorena, Hertze Joakim, Nägga Katarina, Nilsson Karin, Nilsson Christer, Wennström Malin, van Westen Danielle, Blennow Kaj, Zetterberg Henrik, Hansson Oskar

机构信息

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Memory Clinic, Skåne University Hospital, Malmö, Sweden.

出版信息

Neurobiol Aging. 2017 Mar;51:104-112. doi: 10.1016/j.neurobiolaging.2016.11.017. Epub 2016 Dec 5.

DOI:10.1016/j.neurobiolaging.2016.11.017
PMID:28061383
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5754327/
Abstract

Blood-brain barrier (BBB) dysfunction might be an important component of many neurodegenerative disorders. In this study, we investigated its role in dementia using large clinical cohorts. The cerebrospinal fluid (CSF)/plasma albumin ratio (Qalb), an indicator of BBB (and blood-CSF barrier) permeability, was measured in a total of 1015 individuals. The ratio was increased in patients with Alzheimer's disease, dementia with Lewy bodies or Parkinson's disease dementia, subcortical vascular dementia, and frontotemporal dementia compared with controls. However, this measure was not changed during preclinical or prodromal Alzheimer's disease and was not associated with amyloid positron emission tomography or APOE genotype. The Qalb was increased in diabetes mellitus and correlated positively with CSF biomarkers of angiogenesis and endothelial dysfunction (vascular endothelial growth factor, intracellular adhesion molecule 1, and vascular cell adhesion molecule 1). In healthy elderly, high body mass index and waist-hip ratio predicted increased Qalb 20 years later. In summary, BBB permeability is increased in major dementia disorders but does not relate to amyloid pathology or APOE genotype. Instead, BBB impairment may be associated with diabetes and brain microvascular damage.

摘要

血脑屏障(BBB)功能障碍可能是许多神经退行性疾病的一个重要组成部分。在本研究中,我们使用大型临床队列研究了其在痴呆症中的作用。共对1015名个体测量了脑脊液(CSF)/血浆白蛋白比率(Qalb),这是BBB(以及血脑脊液屏障)通透性的一个指标。与对照组相比,阿尔茨海默病、路易体痴呆或帕金森病痴呆、皮质下血管性痴呆和额颞叶痴呆患者的该比率升高。然而,在临床前或前驱期阿尔茨海默病期间,这一指标没有变化,并且与淀粉样蛋白正电子发射断层扫描或APOE基因型无关。糖尿病患者的Qalb升高,并且与血管生成和内皮功能障碍的CSF生物标志物(血管内皮生长因子、细胞间黏附分子1和血管细胞黏附分子1)呈正相关。在健康老年人中,高体重指数和腰臀比预示20年后Qalb会升高。总之,主要痴呆症疾病中BBB通透性增加,但与淀粉样蛋白病理学或APOE基因型无关。相反,BBB损伤可能与糖尿病和脑微血管损伤有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/fccedf886c64/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/2e98e0784ca7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/c3397107a365/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/fccedf886c64/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/2e98e0784ca7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/c3397107a365/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf4/5754327/fccedf886c64/gr3.jpg

相似文献

1
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.血脑屏障通透性增加与痴呆症和糖尿病有关,但与淀粉样蛋白病理或载脂蛋白E基因型无关。
Neurobiol Aging. 2017 Mar;51:104-112. doi: 10.1016/j.neurobiolaging.2016.11.017. Epub 2016 Dec 5.
2
Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia.阿尔茨海默病病理学:不同类型痴呆患者队列中慢性血管危险因素与血脑屏障功能障碍之间的通路
Front Aging Neurosci. 2023 May 4;15:1088140. doi: 10.3389/fnagi.2023.1088140. eCollection 2023.
3
Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia.在一组不同类型痴呆患者中,研究载脂蛋白E(ApoE)基因分型与通过脑脊液-血清白蛋白比率测量的血脑屏障功能障碍之间的关联。
PLoS One. 2013 Dec 27;8(12):e84405. doi: 10.1371/journal.pone.0084405. eCollection 2013.
4
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.路易体痴呆患者脑脊液中载脂蛋白 E 水平升高与痴呆有关。
Alzheimers Dement. 2014 Sep;10(5):530-540.e1. doi: 10.1016/j.jalz.2013.03.010. Epub 2013 Aug 24.
5
Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.血管危险因素对阿尔茨海默病连续体中血脑屏障和脑脊液生物标志物的影响:一项回顾性观察研究。
J Alzheimers Dis. 2024;97(2):599-607. doi: 10.3233/JAD-230792.
6
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
7
Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.将 APOE-ε4、血脑屏障功能障碍和炎症与阿尔茨海默病病理联系起来。
Neurobiol Aging. 2020 Jan;85:96-103. doi: 10.1016/j.neurobiolaging.2019.09.020. Epub 2019 Oct 15.
8
Increased albumin CSF/serum ratio in dementia with Lewy bodies.路易体痴呆患者脑脊液/血清白蛋白比值升高。
J Neurol Sci. 2015 Nov 15;358(1-2):398-403. doi: 10.1016/j.jns.2015.10.011. Epub 2015 Oct 23.
9
Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.脑脊液/血浆白蛋白比值作为神经退行性痴呆血脑屏障损伤的生物标志物。
J Alzheimers Dis. 2020;75(2):429-436. doi: 10.3233/JAD-200168.
10
Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.血脑屏障通透性与内侧颞叶萎缩相关,但与阿尔茨海默病中β淀粉样蛋白跨血脑屏障的转运无关。
Dement Geriatr Cogn Disord. 2007;23(4):241-5. doi: 10.1159/000100019. Epub 2007 Feb 19.

引用本文的文献

1
Navigation Between Alzheimer's Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology-Genetics and Neuroinflammation.阿尔茨海默病(AD)与其各种病理生理轨迹之间的关联:与神经免疫学-遗传学及神经炎症的致病联系
Int J Mol Sci. 2025 Aug 26;26(17):8253. doi: 10.3390/ijms26178253.
2
Kapβ2 Reverses Sevoflurane-Induced Hydrogel Phase Transition of hnRNPA2/B1-SG in Hypoxic Primary Rat Hippocampal Neurons.Kapβ2逆转七氟醚诱导的缺氧原代大鼠海马神经元中hnRNPA2/B1-SG的水凝胶相变
CNS Neurosci Ther. 2025 Aug;31(8):e70532. doi: 10.1111/cns.70532.
3
Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders.

本文引用的文献

1
Plasma β-amyloid in Alzheimer's disease and vascular disease.阿尔茨海默病和血管性疾病中的血浆β-淀粉样蛋白。
Sci Rep. 2016 May 31;6:26801. doi: 10.1038/srep26801.
2
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
3
Establishment and Dysfunction of the Blood-Brain Barrier.血脑屏障的建立和功能障碍。
精神分裂症谱系障碍中血脑屏障完整性、心脏代谢和炎症因子之间的关系。
Brain Behav Immun Health. 2025 May 27;47:101024. doi: 10.1016/j.bbih.2025.101024. eCollection 2025 Aug.
4
SEW2871 Attenuates Blood-Brain Barrier Damage and Neuropathological Outcomes Related to Cerebral Small Vessel Disease.SEW2871减轻与脑小血管疾病相关的血脑屏障损伤和神经病理学后果。
Stroke. 2025 Aug;56(8):2291-2305. doi: 10.1161/STROKEAHA.124.050452. Epub 2025 Jun 3.
5
Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer's disease.外周血的转化疾病模型确定了预测阿尔茨海默病的2型糖尿病生物标志物。
NPJ Syst Biol Appl. 2025 May 29;11(1):58. doi: 10.1038/s41540-025-00539-5.
6
Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups.血脑屏障通透性因脑区和APOE4状态而异,且在高阿尔茨海默病风险组中与脑微结构相关。
Neuroimage Clin. 2025;46:103805. doi: 10.1016/j.nicl.2025.103805. Epub 2025 May 17.
7
Immunological Fluid Biomarkers in Frontotemporal Dementia: A Systematic Review.额颞叶痴呆的免疫体液生物标志物:一项系统评价。
Biomolecules. 2025 Mar 24;15(4):473. doi: 10.3390/biom15040473.
8
The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player.健康与阿尔茨海默病中的微循环、血脑屏障和神经血管单元:异常周细胞是关键因素。
Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.
9
Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia.人类认知障碍和痴呆症中血脑屏障及神经血管单元完整性的生物标志物
Alzheimers Dement. 2025 Mar;21(3):e70104. doi: 10.1002/alz.70104.
10
Bone-brain interaction: mechanisms and potential intervention strategies of biomaterials.骨-脑相互作用:生物材料的作用机制及潜在干预策略
Bone Res. 2025 Mar 17;13(1):38. doi: 10.1038/s41413-025-00404-5.
Cell. 2015 Nov 19;163(5):1064-1078. doi: 10.1016/j.cell.2015.10.067.
4
Increased CSF biomarkers of angiogenesis in Parkinson disease.帕金森病中脑脊液血管生成生物标志物增加。
Neurology. 2015 Nov 24;85(21):1834-42. doi: 10.1212/WNL.0000000000002151. Epub 2015 Oct 28.
5
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies.阿尔茨海默病模型中广泛的血脑屏障破坏缺乏:关注治疗性抗体。
Neuron. 2015 Oct 21;88(2):289-97. doi: 10.1016/j.neuron.2015.09.036.
6
Increased albumin CSF/serum ratio in dementia with Lewy bodies.路易体痴呆患者脑脊液/血清白蛋白比值升高。
J Neurol Sci. 2015 Nov 15;358(1-2):398-403. doi: 10.1016/j.jns.2015.10.011. Epub 2015 Oct 23.
7
The molecular constituents of the blood-brain barrier.血脑屏障的分子组成成分。
Trends Neurosci. 2015 Oct;38(10):598-608. doi: 10.1016/j.tins.2015.08.003.
8
Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.阿尔茨海默病发病机制中的血管功能障碍——内皮细胞介导机制及随后的恶性循环综述。
Neurobiol Dis. 2015 Oct;82:593-606. doi: 10.1016/j.nbd.2015.08.014. Epub 2015 Aug 23.
9
Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.重组组织型纤溶酶原激活剂通过血管内皮生长因子介导的内皮细胞内吞作用,在小鼠脑缺血期间短暂增强血脑屏障通透性。
J Cereb Blood Flow Metab. 2015 Dec;35(12):2021-31. doi: 10.1038/jcbfm.2015.167. Epub 2015 Jul 29.
10
The neuropathology and cerebrovascular mechanisms of dementia.痴呆的神经病理学和脑血管机制。
J Cereb Blood Flow Metab. 2016 Jan;36(1):172-86. doi: 10.1038/jcbfm.2015.164.